List of Tables
    Table 1. Gene Therapy in Oncology Market Opportunities & Trends in Global Market
    Table 2. Gene Therapy in Oncology Market Drivers in Global Market
    Table 3. Gene Therapy in Oncology Market Restraints in Global Market
    Table 4. Key Players of Gene Therapy in Oncology in Global Market
    Table 5. Top Gene Therapy in Oncology Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Gene Therapy in Oncology Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Gene Therapy in Oncology Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Gene Therapy in Oncology Product Type
    Table 9. List of Global Tier 1 Gene Therapy in Oncology Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Gene Therapy in Oncology Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Gene Therapy in Oncology Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Gene Therapy in Oncology Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Gene Therapy in Oncology Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Gene Therapy in Oncology Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Gene Therapy in Oncology Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Gene Therapy in Oncology Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Gene Therapy in Oncology Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Gene Therapy in Oncology Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Gene Therapy in Oncology Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Gene Therapy in Oncology Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Gene Therapy in Oncology Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Gene Therapy in Oncology Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Gene Therapy in Oncology Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Gene Therapy in Oncology Revenue, (US$, Mn), 2023-2028
    Table 30. Bristol-Myers Squibb Corporate Summary
    Table 31. Bristol-Myers Squibb Gene Therapy in Oncology Product Offerings
    Table 32. Bristol-Myers Squibb Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 33. Cold Genesys Corporate Summary
    Table 34. Cold Genesys Gene Therapy in Oncology Product Offerings
    Table 35. Cold Genesys Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 36. Advantagene Corporate Summary
    Table 37. Advantagene Gene Therapy in Oncology Product Offerings
    Table 38. Advantagene Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 39. Amgen Corporate Summary
    Table 40. Amgen Gene Therapy in Oncology Product Offerings
    Table 41. Amgen Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 42. AstraZeneca Corporate Summary
    Table 43. AstraZeneca Gene Therapy in Oncology Product Offerings
    Table 44. AstraZeneca Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 45. Bio-Path Holdings Corporate Summary
    Table 46. Bio-Path Holdings Gene Therapy in Oncology Product Offerings
    Table 47. Bio-Path Holdings Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 48. CRISPR Therapeutics Corporate Summary
    Table 49. CRISPR Therapeutics Gene Therapy in Oncology Product Offerings
    Table 50. CRISPR Therapeutics Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 51. Editas Medicine Corporate Summary
    Table 52. Editas Medicine Gene Therapy in Oncology Product Offerings
    Table 53. Editas Medicine Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 54. Geron Corp Corporate Summary
    Table 55. Geron Corp Gene Therapy in Oncology Product Offerings
    Table 56. Geron Corp Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 57. Idera Pharmaceuticals Corporate Summary
    Table 58. Idera Pharmaceuticals Gene Therapy in Oncology Product Offerings
    Table 59. Idera Pharmaceuticals Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 60. Intellia Therapeutics Corporate Summary
    Table 61. Intellia Therapeutics Gene Therapy in Oncology Product Offerings
    Table 62. Intellia Therapeutics Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 63. Johnson & Johnson Corporate Summary
    Table 64. Johnson & Johnson Gene Therapy in Oncology Product Offerings
    Table 65. Johnson & Johnson Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 66. Marsala Biotech Corporate Summary
    Table 67. Marsala Biotech Gene Therapy in Oncology Product Offerings
    Table 68. Marsala Biotech Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 69. Merck Corporate Summary
    Table 70. Merck Gene Therapy in Oncology Product Offerings
    Table 71. Merck Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 72. Mologen AG Corporate Summary
    Table 73. Mologen AG Gene Therapy in Oncology Product Offerings
    Table 74. Mologen AG Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 75. Oncolytics Biotech Corporate Summary
    Table 76. Oncolytics Biotech Gene Therapy in Oncology Product Offerings
    Table 77. Oncolytics Biotech Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 78. Oncosec Corporate Summary
    Table 79. Oncosec Gene Therapy in Oncology Product Offerings
    Table 80. Oncosec Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 81. Oncotelic Corporate Summary
    Table 82. Oncotelic Gene Therapy in Oncology Product Offerings
    Table 83. Oncotelic Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 84. Shenzhen SiBiono GeneTech Corporate Summary
    Table 85. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Offerings
    Table 86. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 87. Sillajen Biotherapeutics Corporate Summary
    Table 88. Sillajen Biotherapeutics Gene Therapy in Oncology Product Offerings
    Table 89. Sillajen Biotherapeutics Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 90. Tocagen Corporate Summary
    Table 91. Tocagen Gene Therapy in Oncology Product Offerings
    Table 92. Tocagen Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 93. UniQure Corporate Summary
    Table 94. UniQure Gene Therapy in Oncology Product Offerings
    Table 95. UniQure Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
    Table 96. Ziopharm Oncology Corporate Summary
    Table 97. Ziopharm Oncology Gene Therapy in Oncology Product Offerings
    Table 98. Ziopharm Oncology Gene Therapy in Oncology Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Gene Therapy in Oncology Segment by Type in 2021
    Figure 2. Gene Therapy in Oncology Segment by Application in 2021
    Figure 3. Global Gene Therapy in Oncology Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Gene Therapy in Oncology Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Gene Therapy in Oncology Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy in Oncology Revenue in 2021
    Figure 8. By Type - Global Gene Therapy in Oncology Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Gene Therapy in Oncology Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Gene Therapy in Oncology Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Gene Therapy in Oncology Revenue Market Share, 2017-2028
    Figure 12. US Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Gene Therapy in Oncology Revenue Market Share, 2017-2028
    Figure 16. Germany Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 17. France Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Gene Therapy in Oncology Revenue Market Share, 2017-2028
    Figure 24. China Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 28. India Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Gene Therapy in Oncology Revenue Market Share, 2017-2028
    Figure 30. Brazil Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Gene Therapy in Oncology Revenue Market Share, 2017-2028
    Figure 33. Turkey Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Gene Therapy in Oncology Revenue, (US$, Mn), 2017-2028
    Figure 37. Bristol-Myers Squibb Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Cold Genesys Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Advantagene Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Amgen Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. AstraZeneca Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Bio-Path Holdings Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. CRISPR Therapeutics Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Editas Medicine Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Geron Corp Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Idera Pharmaceuticals Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Intellia Therapeutics Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Johnson & Johnson Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Marsala Biotech Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Merck Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Mologen AG Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Oncolytics Biotech Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Oncosec Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Oncotelic Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. Sillajen Biotherapeutics Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 57. Tocagen Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 58. UniQure Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 59. Ziopharm Oncology Gene Therapy in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)